Conclusion Ro's current program is more transparent than the old broad $900-$1,500 branded estimate because it publishes product and dose ranges
[PMID: 10375004] PubMed record related to this compound for laboratory literature review
The FDA does not review or approve compounded medications, including Tirzepatide+, for safety, effectiveness, or quality
Alternatively, use a vitamin C derivative like magnesium ascorbyl phosphate or sodium ascorbyl phosphate, which function at a higher pH and play much more nicely with copper peptides
H., Kamasaka, H., & Kuriki, T
That call belongs entirely to the reviewing clinician